{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T12:58:58Z","timestamp":1754398738622,"version":"3.40.5"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","license":[{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Rapid disease progression in neuroemergencies is associated with blood-brain barrier (BBB) disruption. We investigated a less invasive strategy for assessing BBB status by evaluating S100 calcium-binding protein B (S100B) and neuron-specific enolase (NSE) at early stages of the hypoxic-ischemic brain injury (HIBI) cascade.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This retrospective study used prospectively collected data from patients with out-of-hospital cardiac arrest (August 2019\u2013July 2021). Albumin specimens obtained from serum and cerebrospinal fluid via arterial catheter and lumbar puncture were used to measure the albumin quotient (Qa), which is widely accepted as the gold standard method for detecting BBB disruption. Serum S100B and NSE levels were measured simultaneously following the return of spontaneous circulation. We conducted linear regression to evaluate the relationship between S100B and Qa and the predictive performance of S100B for abnormal Qa. The primary study outcome was abnormal Qa (&gt;0.007).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Forty-one patients were enrolled; 30 showed an abnormal Qa suggestive of BBB disruption. S100B levels were significantly higher than in those with a normal Qa (0.244 \u03bcg\/L [interquartile range [IQR], 0.146\u20130.823 vs 0.754 \u03bcg\/L [IQR, 0.317\u20132.228], <jats:italic toggle=\"yes\">P<\/jats:italic> = .03). We report a positive correlation between serum S100B and Qa (R<jats:sup>2<\/jats:sup> = 0.110; <jats:italic toggle=\"yes\">P<\/jats:italic> = .04). The area under the receiver operating characteristics curve (AUROC) evaluating the predictive performance of S100B with respect to abnormal Qa was 0.718 (95% confidence interval, 0.556\u20130.847). The cutoff value for S100B (with respect to BBB disruption) in the total cohort was 0.283 \u03bcg\/L (sensitivity, 80.0%; specificity, 72.7%). Subgroup analyses in patients with serum neuron-specific enolase (NSE) levels of &lt;40.8 ng\/mL (excluding those with established neuronal cell injury) showed an improved correlation coefficient (R<jats:sup>2<\/jats:sup> = 0.382; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .01) and predictive performance (AUROC, 0.836 [95% confidence interval, 0.629\u20130.954]) compared with the total cohort.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Serum S100B obtained at an early stage of the HIBI cascade is associated with abnormal Qa, suggesting BBB disruption. The predictive performance of S100B and the correlation between serum S100B and Qa can be improved using a complementary strategy (i.e., evaluations of S100B and NSE levels) that combines considerations of cell damage in astrocytes and neurons.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000029644","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T15:20:16Z","timestamp":1662650416000},"page":"e29644","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Development of a strategy for assessing blood-brain barrier disruption using serum S100 calcium-binding protein B and neuron-specific enolase in early stage of neuroemergencies: A preliminary study"],"prefix":"10.1097","volume":"101","author":[{"given":"Gi Su","family":"Yun","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, Chungnam National University Hospital, Jung-gu, Daejeon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Nam","family":"In","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, College of Medicine, Chungnam National University, Jung-gu, Daejeon, Republic of Korea"},{"name":"Department of Emergency Medicine, Chungnam National University Sejong Hospital, Sejong, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8848-5062","authenticated-orcid":false,"given":"Changshin","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Chungnam National University Hospital, Jung-gu, Daejeon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Soo","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Chungnam National University Hospital, Jung-gu, Daejeon, Republic of Korea"},{"name":"Department of Emergency Medicine, College of Medicine, Chungnam National University, Jung-gu, Daejeon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeonho","family":"You","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Chungnam National University Hospital, Jung-gu, Daejeon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Hong","family":"Min","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, College of Medicine, Chungnam National University, Jung-gu, Daejeon, Republic of Korea"},{"name":"Department of Emergency Medicine, Chungnam National University Sejong Hospital, Sejong, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong Joon","family":"Ahn","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Chungnam National University Hospital, Jung-gu, Daejeon, Republic of Korea"},{"name":"Department of Emergency Medicine, College of Medicine, Chungnam National University, Jung-gu, Daejeon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Insool","family":"Yoo","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Chungnam National University Hospital, Jung-gu, Daejeon, Republic of Korea"},{"name":"Department of Emergency Medicine, College of Medicine, Chungnam National University, Jung-gu, Daejeon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Whan","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Chungnam National University Hospital, Jung-gu, Daejeon, Republic of Korea"},{"name":"Department of Emergency Medicine, College of Medicine, Chungnam National University, Jung-gu, Daejeon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se Kwang","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, College of Medicine, Chungnam National University, Jung-gu, Daejeon, Republic of Korea"},{"name":"Department of Emergency Medicine, Chungnam National University Sejong Hospital, Sejong, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In Ho","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Radiology, College of Medicine, Chungnam National University, Jung-gu, Daejeon, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da Mi","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Radiology, College of Medicine, Chungnam National University, Jung-gu, Daejeon, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,7,15]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev-cellbio-100617-062608","article-title":"Development and cell biology of the blood\u2013brain barrier","volume":"35","author":"Langen","year":"2019","journal-title":"Annu Rev Cell Dev Biol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"a020412a020412","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood\u2013brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev-cellbio-100818-125142","article-title":"Neurovascular interactions in the nervous system","volume":"35","author":"Segarra","year":"2019","journal-title":"Annu Rev Cell Dev Biol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.tins.2020.12.002","article-title":"Blood\u2013brain barrier dynamics to maintain brain homeostasis","volume":"44","author":"Segarra","year":"2021","journal-title":"Trends Neurosci"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1161\/STROKEAHA.110.608257","article-title":"Blood\u2013brain barrier breakdown in acute and chronic cerebrovascular disease","volume":"42","author":"Yang","year":"2011","journal-title":"Stroke"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"101483","DOI":"10.1016\/j.arr.2021.101483","article-title":"Interactions between glial cells and the blood\u2013brain barrier and their role in Alzheimer\u2019s disease","volume":"72","author":"Zhao","year":"2021","journal-title":"Ageing Res Rev"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp.57.8.897","article-title":"Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report","volume":"57","author":"Andersson","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1089\/089771501316919139","article-title":"Intrathecal levels of complement-derived soluble membrane attack complex (sc5b-9) correlate with blood\u2013brain barrier dysfunction in patients with traumatic brain injury","volume":"18","author":"Stahel","year":"2001","journal-title":"J Neurotrauma"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0009-8981(87)90250-6","article-title":"Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system","volume":"163","author":"Reiber","year":"1987","journal-title":"Clin Chim Acta"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1007\/s12630-021-02110-2","article-title":"S100B as a biomarker of blood\u2013brain barrier disruption after thoracoabdominal aortic aneurysm repair: a secondary analysis from a prospective cohort study","volume":"68","author":"Roberts","year":"2021","journal-title":"Can J Anaesth"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s40279-013-0119-9","article-title":"S100B as a marker for brain damage and blood\u2013brain barrier disruption following exercise. Sports","volume":"44","author":"Koh","year":"2014","journal-title":"Sports Med"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.athoracsur.2012.04.044","article-title":"Cerebrospinal fluid markers of brain injury, inflammation, and blood\u2013brain barrier dysfunction in cardiac surgery","volume":"94","author":"Reinsfelt","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0006-8993(02)02586-6","article-title":"Serum S-100beta as a possible marker of blood\u2013brain barrier disruption","volume":"940","author":"Kapural","year":"2002","journal-title":"Brain Res"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1523\/JNEUROSCI.23-05-01949.2003","article-title":"Serum transthyretin monomer as a possible marker of blood-to-csf barrier disruption","volume":"23","author":"Marchi","year":"2003","journal-title":"J Neurosci"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1089\/neu.2008.0738","article-title":"Validation of serum markers for blood\u2013brain barrier disruption in traumatic brain injury","volume":"26","author":"Blyth","year":"2009","journal-title":"J Neurotrauma"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/WCO.0000000000000248","article-title":"Blood\u2013brain barrier breakdown and neovascularization processes after stroke and traumatic brain injury","volume":"28","author":"Prakash","year":"2015","journal-title":"Curr Opin Neurol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.resuscitation.2020.05.050","article-title":"Impact of low and high partial pressure of carbon dioxide on neuron-specific enolase derived from serum and cerebrospinal fluid in patients who underwent targeted temperature management after out-of-hospital cardiac arrest: a retrospective study","volume":"153","author":"Kang","year":"2020","journal-title":"Resuscitation"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1212\/WNL.0000000000012967","article-title":"Serum neuron-specific enolase thresholds for predicting postcardiac arrest outcome: a systematic review and meta-analysis","volume":"98","author":"Sharma","year":"2022","journal-title":"Neurology"},{"key":"R19-20250504","first-page":"109","article-title":"Peripheral markers of brain damage and blood\u2013brain barrier dysfunction","volume":"21","author":"Marchi","year":"2003","journal-title":"Restor Neurol Neurosci"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1161\/STROKEAHA.115.009099","article-title":"Mitochondrial crisis in cerebrovascular endothelial cells opens the blood\u2013brain barrier","volume":"46","author":"Doll","year":"2015","journal-title":"Stroke"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.3390\/ijms21093344","article-title":"Mechanisms of blood\u2013brain barrier dysfunction in traumatic brain injury","volume":"21","author":"Cash","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1161\/STROKEAHA.106.480111","article-title":"Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke","volume":"38","author":"Foerch","year":"2007","journal-title":"Stroke"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/neu.2006.23.149","article-title":"Rapid elimination of protein S-100B from serum after minor head trauma","volume":"23","author":"Townend","year":"2006","journal-title":"J Neurotrauma"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood\u2013brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"R25-20250504","first-page":"274","article-title":"Abnormalities of the blood\u2013brain barrier in global cerebral ischemia in rats due to experimental cardiac arrest","volume":"60","author":"Mossakowski","year":"1994","journal-title":"Acta Neurochir Suppl (Wien)"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0006-8993(94)91520-2","article-title":"Early blood\u2013brain barrier changes in the rat following transient complete cerebral ischemia induced by cardiac arrest","volume":"633","author":"Pluta","year":"1994","journal-title":"Brain Res"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-510X(94)90298-4","article-title":"Flow rate of cerebrospinal fluid (CSF)\u2014A concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases","volume":"122","author":"Reiber","year":"1994","journal-title":"J Neurol Sci"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1586\/14737159.8.4.479","article-title":"Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases","volume":"8","author":"Tumani","year":"2008","journal-title":"Expert Rev Mol Diagn"},{"key":"R29-20250504","first-page":"4193","article-title":"Levels of serum S100B are associated with cognitive dysfunction in patients with type 2 diabetes","volume":"12","author":"Yu","year":"2020","journal-title":"Aging (Albany, New York)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029644","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:14:35Z","timestamp":1746332075000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,15]]},"references-count":29,"journal-issue":{"issue":"28","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029644","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2022,7,15]]}}}